Back to School: How biopharma can reboot drug development. Access exclusive analysis here

InSite raises $60M in note deal

InSite (AMEX:ISV) raised $60 million in a private placement of non-convertible promissory notes due 2019. The

Read the full 167 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE